ABSTRACT
We assessed IgM detection in Zika patients from the 2016 outbreak in Miami-Dade County, Florida, USA. Of those with positive or equivocal IgM after 12-19 months, 87% (26/30) had IgM 6 months later. In a survival analysis, ≈76% had IgM at 25 months. Zika virus IgM persists for years, complicating serologic diagnosis.
Subject(s)
Antibodies, Viral/immunology , Immunoglobulin M/immunology , Zika Virus Infection/epidemiology , Zika Virus Infection/immunology , Zika Virus/immunology , Adult , Aged , Antibodies, Viral/blood , Disease Outbreaks , Female , Florida/epidemiology , Humans , Immunoglobulin M/blood , Male , Middle Aged , Time Factors , Young Adult , Zika Virus/genetics , Zika Virus Infection/diagnosis , Zika Virus Infection/virologyABSTRACT
BACKGROUND: Chikungunya virus (CHIKV) represents a threat to the United States, because humans amplify CHIKV and vectors that transmit CHIKV are present. METHODS: We described the epidemiology of laboratory-confirmed chikungunya fever (CHIK) cases in the United States in 1995-2009 and compared states with CHIKV vectors with states with returning viremic CHIK cases. For 2006-2009, we evaluated reporting of CHIK cases to ArboNET, the arboviral surveillance system. RESULTS: In 1995-2009, 109 CHIK cases were identified in the United States; all adult travelers. Sixty-two subjects (57%) had recently visited India, and 13 (12%) had CHIKV viremia. Of the 26 jurisdictions with CHIK cases, 22 (85%) reported the presence of CHIKV vectors. Twelve viremic travelers returned to 6 states with CHIKV vectors. Of the 106 cases identified in 2006-2009, only 27 (25%) were reported to ArboNET, with a median of 122 days (range, 44-273 days) between illness onset and reporting. CONCLUSIONS: No locally acquired CHIK cases were identified. However, several viremic travelers returned to states with CHIKV vectors and presented a risk for local transmission. Incomplete and delayed reporting made ArboNET less useful. To minimize the risk of CHIKV spread in the United States, healthcare providers and public health officials should be educated about recognition, diagnosis, and reporting of CHIK cases.
Subject(s)
Chikungunya virus/isolation & purification , Adult , Aged , Alphavirus Infections/epidemiology , Chikungunya Fever , Female , Humans , Incidence , Male , Middle Aged , Travel , United States/epidemiologyABSTRACT
Zika virus (ZIKV) is a mosquito-borne flavivirus first isolated in Uganda from a sentinel monkey in 1947. Mosquito and sentinel animal surveillance studies have demonstrated that ZIKV is endemic to Africa and Southeast Asia, yet reported human cases are rare, with <10 cases reported in the literature. In June 2007, an epidemic of fever and rash associated with ZIKV was detected in Yap State, Federated States of Micronesia. We report the genetic and serologic properties of the ZIKV associated with this epidemic.
Subject(s)
Disease Outbreaks , Zika Virus Infection , Zika Virus , Antibodies, Viral/blood , Base Sequence , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Micronesia/epidemiology , Phylogeny , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Serologic Tests , Zika Virus/genetics , Zika Virus/isolation & purification , Zika Virus Infection/diagnosis , Zika Virus Infection/epidemiology , Zika Virus Infection/virologySubject(s)
Meningitis, Viral/diagnosis , Phlebotomus Fever/diagnosis , Sandfly fever Naples virus , Aged , Base Sequence , Communicable Diseases, Emerging/diagnosis , Communicable Diseases, Emerging/virology , DNA Primers/genetics , DNA, Viral/genetics , Genotype , Humans , Italy , Male , Meningitis, Viral/virology , Phlebotomus Fever/virology , Phylogeny , Sandfly fever Naples virus/classification , Sandfly fever Naples virus/genetics , Sandfly fever Naples virus/isolation & purification , Travel , United StatesABSTRACT
St. Louis encephalitis (SLE) and West Nile (WN) flaviviruses are genetically closely related and cocirculate in the United States. Virus neutralization tests provide the most specific means for serodiagnosis of infections with these viruses. However, use of wild-type SLE and WN viral strains for laboratory testing is constrained by the biocontainment requirements. We constructed two highly attenuated yellow fever (YF) virus chimeras that contain the premembrane-envelope (prM-E) protein genes from the virulent MSI-7 (isolated in the United States) or the naturally attenuated CorAn9124 (Argentina) SLE strains. The YF/SLE (CorAn version) virus and the previously constructed YF/WN chimera were shown to specifically distinguish between confirmed human SLE and WN cases in a virus neutralization test using patient sera. These chimeras have the potential for use as diagnostic reagents and vaccines against SLE and WN.
Subject(s)
Encephalitis Virus, St. Louis/isolation & purification , Encephalitis, St. Louis/prevention & control , Genes, Viral/genetics , Viral Vaccines/chemical synthesis , Yellow Fever/prevention & control , Yellow fever virus/isolation & purification , Amino Acid Sequence , Animals , Argentina/epidemiology , Culex/virology , Encephalitis Virus, St. Louis/genetics , Encephalitis Virus, St. Louis/immunology , Encephalitis, St. Louis/epidemiology , Encephalitis, St. Louis/transmission , Humans , Mice , Molecular Sequence Data , Recombinant Fusion Proteins/genetics , Sequence Alignment , United States/epidemiology , Viral Vaccines/therapeutic use , Yellow Fever/epidemiology , Yellow Fever/transmission , Yellow fever virus/genetics , Yellow fever virus/immunologyABSTRACT
To investigate the infection status and the spatial distribution of Tahyna virus infection among unknown fever cases in Xinjiang, China. Sera samples of unknown fever cases from Kashi in southern Xin-jiang and Yili in northern Xinjiang were tested against Tahyna virus by IFA. Partial positive cases were tested against Tahyna virus/Snowshoe hare virus/Inkoo virus parrelled. Finally, 742 sera samples of unknown fever cases were collected from Kashi, Southern Xinjiang in 2007-2008, the positive rate of IgM antibody against Tahyna virus was 5.3%, the positive rate of IgG antibody against Tahyna virus was 18.3%. 222 sera samples of unknown fever cases were collected from Yili, Northern Xinjiang in 2008, no positive case of IgM antibody against Tahyna was found. 10 cases showed antibody neutralization against Tahyna virus by plaque reduction neutralization test. Our results demonstrate that there is current infection and past infection of Tahyna virus among Southern Xinjiang residents.
Subject(s)
Encephalitis Virus, California/physiology , Encephalitis, California/virology , Fever/virology , Adolescent , Adult , Antibodies, Viral/blood , Child , Child, Preschool , China/epidemiology , Encephalitis Virus, California/immunology , Encephalitis, California/blood , Encephalitis, California/epidemiology , Female , Fever/blood , Fever/epidemiology , Humans , Immunoglobulin M/blood , Infant , Male , Middle Aged , Young AdultABSTRACT
Serum antibodies from myriad species, particularly birds, can provide key information regarding the transmission and the expansion of the territory of emerging pathogens. Expedient antibody analysis is constrained by a lack of species-specific reagents, a deficiency potentially highlighted by the recent swine-origin influenza A virus (H1N1) outbreak. Available methodologies present difficulties that discourage thorough serologic monitoring of potential disease vectors or hosts. Rapid high-throughput procedures that combined serum amine labeling via biotinylation, contaminant removal, and microsphere-based immunoassays for antibodies to three arboviruses were developed. Agent-specific adaptations of this simple format should facilitate expanded surveillance and diagnostic capabilities regarding pathogens of human and veterinary importance.
Subject(s)
Antibodies, Viral/blood , Antibodies, Viral/isolation & purification , Clinical Laboratory Techniques/methods , Encephalitis Virus, Eastern Equine/immunology , Encephalitis Virus, St. Louis/immunology , Immunoassay/methods , West Nile virus/immunology , Animals , Humans , MicrospheresABSTRACT
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, is endemic in Africa and Asia. In 2005-2006, CHIKV epidemics were reported in islands in the Indian Ocean and in southern India. We present data on laboratory-confirmed CHIKV infections among travelers returning from India to the United States during 2006.